AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SUTRO BIOPHARMA, INC. Director's Dealing 2024

Mar 22, 2024

Director's Dealing

Opens in your device viewer

Issuer: SUTRO BIOPHARMA, INC. (STRO)
CIK: 0001382101
Period of Report: 2024-03-05

Reporting Person: ALBINI EDWARD C (N/A)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-05	Restricted Stock Units (RSUs)	$	A	69000	Acquired	2028-03-01	Common Stock (69000)	Direct

F1: Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.

F2: The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.